The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies

The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies

Show other versions (1)

Bibliographic Details
Main Authors:	Karamitsos, T, Neubauer, S
Format:	Journal article
Published:	2013

Similar Items

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.
by: Karamitsos, T, et al.
Published: (2013)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies topical collection on cardiac PET, CT, and MRI
by: Karamitsos, T, et al.
Published: (2013)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
by: Marthe A.J. Becker, et al.
Published: (2020-02-01)

Further refining risk in hypertrophic cardiomyopathy with late gadolinium enhancement by CMR
by: Kramer, C, et al.
Published: (2018)

Diabetes mellitus is associated to high-risk late gadolinium enhancement and worse outcomes in patients with nonischemic dilated cardiomyopathy
by: Pablo Zulet, et al.
Published: (2024-01-01)

Can the outcome of post partum cardiomyopathy be predicted using late gadolinium enhancement CMR?
by: Prasad Sanjay, et al.
Published: (2009-01-01)

The current and emerging role of cardiovascular magnetic resonance in the diagnosis of nonischemic cardiomyopathies.
by: Karamitsos, T, et al.
Published: (2011)

Prognostic significance of ventricular function and late gadolinium enhancement on CMR in symptomatic patients with scleroderma
by: Natarajan Arun, et al.
Published: (2013-01-01)

CMR - Late gadolinium enhancement characteristics associated with monomorphic ventricular arrhythmia in patients with non-ischemic cardiomyopathy
by: Priyanka Rajinthan, et al.
Published: (2022-09-01)

Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta-analysis
by: Nonthikorn Theerasuwipakorn, et al.
Published: (2023-08-01)

T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
by: Ferreira, V, et al.
Published: (2013)

T1 Mapping for the diagnosis of acute myocarditis using CMR: Comparison to T2-Weighted and late gadolinium enhanced imaging
by: Ferreira, V, et al.
Published: (2013)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
by: Punyanuch Chayanopparat, et al.
Published: (2023-10-01)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
by: Dibya Ranjan Behera, et al.
Published: (2020-09-01)

Association of Whole-Heart Myocardial Mechanics by Transthoracic Echocardiography with Presence of Late Gadolinium Enhancement by CMR in Non-Ischemic Dilated Cardiomyopathy
by: Karolina Mėlinytė-Ankudavičė, et al.
Published: (2022-11-01)

Deep learning for automated insertion point annotation of CMR late gadolinium enhancement and virtual native enhancement images
by: Gonzales, RA, et al.
Published: (2023)

Added value of contrast echocardiography in characterization of nonischemic cardiomyopathy
by: Shufang Pi, et al.
Published: (2018-11-01)

Ventricular arrhythmias in nonischemic cardiomyopathy
by: Fa‐Po Chung, et al.
Published: (2018-08-01)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.
by: Dass, S, et al.
Published: (2012)

Feasibility of detecting myocardial infarction in the sheep fetus using late gadolinium enhancement CMR imaging
by: An Qi Duan, et al.
Published: (2017-09-01)

Current status of the ICD in nonischemic cardiomyopathy
by: Venkatakrishnan Ramakumar, et al.
Published: (2018-01-01)

Ventricular arrhythmias in nonischemic cardiomyopathy: Overview
by: Kengo Kusano
Published: (2018-08-01)

Role of cardiac MRI in nonischemic cardiomyopathies
by: Senthil Anand, et al.
Published: (2016-05-01)

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy.
by: Konstantinou, D, et al.
Published: (2014)

Determinants of functional mitral regurgitation severity in patients with ischemic cardiomyopathy versus nonischemic dilated cardiomyopathy
by: Konstantinou, D, et al.
Published: (2014)

In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.
by: Dass, S, et al.
Published: (2011)

Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy
by: Farah Cadour, et al.
Published: (2023-02-01)

Low diagnostic yield of Late Gadolinium Enhancement (LGE) in screening patients with suspected Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) by Cardiovascular Magnetic Resonance (CMR)
by: van Hoorn Frans, et al.
Published: (2012-02-01)

Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy
by: Kenji Okubo, et al.
Published: (2018-08-01)

Sudden cardiac death in patients with nonischemic cardiomyopathy
by: Brian P. Betensky, et al.
Published: (2014-01-01)

Free-breathing late gadolinium enhancement CMR with a fixed short scan time using CosMo
by: Moghari Mehdi H, et al.
Published: (2012-02-01)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
by: Smith Brandon M, et al.
Published: (2013-01-01)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
by: Dass, S, et al.
Published: (2012)

Prognostic Value of Late Gadolinium Enhancement in Left Ventricular Noncompaction: A Multicenter Study
by: Wei Huang, et al.
Published: (2022-10-01)

Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics
by: Lynne K. Williams, et al.
Published: (2017-08-01)

Revisiting how we perform late gadolinium enhancement CMR: insights gleaned over 25 years of clinical practice
by: Elizabeth R. Jenista, et al.
Published: (2023-03-01)

2070 Mitral valve prolapse is associated with abnormal CMR late gadolinium enhancement of the mitral valve leaflets and the papillary muscles
by: Zimetbaum Peter J, et al.
Published: (2008-10-01)

Myocardial Late Gadolinium Enhancement (LGE) in Cardiac Magnetic Resonance Imaging (CMR)—An Important Risk Marker for Cardiac Disease
by: Claudia Meier, et al.
Published: (2024-01-01)

Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy
by: Zhang, Q, et al.
Published: (2021)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)